The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB).

Source:http://linkedlifedata.com/resource/pubmed/id/2408771

Download in:

View as

General Info

PMID
2408771